Intermittent Pneumatic Compression Device for Vein Dilation in Kidney Disease Patients to Enable … (NCT04063787) | Clinical Trial Compass
CompletedNot Applicable
Intermittent Pneumatic Compression Device for Vein Dilation in Kidney Disease Patients to Enable AVF Creation (FACT)
United States46 participantsStarted 2019-05-13
Plain-language summary
This is a single center pilot study that is seeking to determine whether the use of the Fist Assist® device for 360 hours over 90 days by patients with advanced CKD prior to AVF surgery results in significant increases in cephalic vein diameters prior to AVF surgery.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 and older
* Followed in the University of Chicago Medical Center's Nephrology Clinic
* Expected to initiate hemodialysis
* Estimated Glomerular Filtration Rate (eGFR) \<30 mL/min.1.73m
Exclusion criteria:
* Refusal/inability to give informed consent
* Inability to comply with trial requirements,
* Arm infections and/or skin disorders that require frequent medical attention.
* Patients with obvious scarring from IV drug use
* Previous phlebitis.
* Previous occluded arteriovenous grafts or fistulae
* Arterial aneurysms
* Arm deep vein thrombosis
* Any previous vascular surgery on the non-dominant arm.
* Limited cognitive ability
* Motor or sensory deficits in the upper arm
* Upon preliminary evaluation of the cephalic vein (measured 5 cm proximal to the styloid process of the radius, and at the antecubital fossa) there are no detectable superficial veins of at least 1.0 mm diameter, or superficial vein of more than 3.0 mm is present in this lower arm location.